The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Investor
26.01.2026
Q4 2025: GPI continues international growth
€27 million in new contracts signed in the last quarter of 2025
Investor
19.01.2026
Welsh Blood Service chooses Gpi
Ten-year contract worth £6.5 million for the blood transfusion information system
Investor
23.12.2025
New governance structure for Gpi
Fausto Manzana appointed Executive Chairman, Andrea Di Santo Chief Executive Officer
